Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Memory boost: personalized scenarios may help Alzheimer's patients stay oriented

NCT ID NCT07548073

Symptom relief Sponsor: Zhejiang Provincial Tongde Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a training program for people with mild to moderate Alzheimer's disease. The training used personal photos and videos to recreate familiar situations, aiming to improve orientation to time, place, and person. 126 participants were assigned to either the training group (3 sessions per week for 3 months) or usual care. The study measured thinking skills and orientation to see if this non-drug approach could help.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

126 people

The number who actually took part.

Started

Jan 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 60 years * Diagnosis of mild to moderate Alzheimer's disease according to DSM-5 criteria * Ability to communicate and complete cognitive assessments * Stable caregiver available to assist with intervention and follow-up * Visual and auditory function adequate to participate in assessments (with or without correction) * Willingness to participate and provide informed consent (by patient or legal guardian) Exclusion Criteria: * Severe psychiatric disorders (e.g., severe depression, schizophrenia) * Severe cardiovascular, cerebrovascular, or other systemic diseases affecting participation * History of neurological disorders other than Alzheimer's disease (e.g., Parkinson's disease, stroke with major deficits) * Severe sensory impairment (vision or hearing) that interferes with intervention or assessment * Inability to complete study procedures or comply with follow-up * Participation in other interventional clinical trials within the past 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alzheimer disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease cognitive disorder Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alzheimer disease Cognitive dysfunction Mild cognitive impairment

Contacts and locations

Locations

  • Tongde Hospital of Zhejiang Province

    Hangzhou, Zhejiang, 310012, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.